Middle East News Dispatch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Dispatch.

Press releases published on June 4, 2026

Jun. 4, 2026

KELA Research Finds 4,300+ Fraudulent Domains and 1.5 Million Compromised AccountsTargeting 2026 FIFA World Cup

Indeterminate GlobeNewswire

Jun. 4, 2026

Cosmos Health Identifies Approximately $20 Million in Non-Core Assets Available for Monetization to Accelerate Growth and Unlock Shareholder Value

Indeterminate GlobeNewswire

Jun. 4, 2026

AIM ImmunoTech Releases Virtual Investor ‘What This Means’ Video Segment Discussing Ampligen’s Potential in Ebola Virus Disease Preparedness

Indeterminate GlobeNewswire

Jun. 4, 2026

Teva Expands European biosimilars portfolio with launch of AHZANTIVE® (aflibercept) biosimilar to Eylea®

Indeterminate GlobeNewswire

Jun. 4, 2026

RenovoRx CEO, Shaun Bagai, to Present at the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2026 on June 23rd

Indeterminate GlobeNewswire

Jun. 4, 2026

Quoin Pharmaceuticals Announces Japan's MHLW Grants Orphan Drug Designation for QRX003 in Netherton Syndrome

Indeterminate GlobeNewswire

Jun. 4, 2026

Fate Therapeutics Showcases Data from FT819 and FT839 Programs at the European Congress of Rheumatology Annual Meeting

Indeterminate GlobeNewswire

Jun. 4, 2026

GoldHaven Advances Copeçal Toward Q3 Drilling; Identifies Priority Eastern Targets

Indeterminate GlobeNewswire

Jun. 4, 2026

Oncotelic Therapeutics Inc. (OTCQB: OTLC) Eyeing Nanotech-Driven Delivery Systems, Pharmacokinetic Optimization to Advance Existing Oncology Therapies

Indeterminate GlobeNewswire

Jun. 4, 2026

Nexera Technologies Announces Receipt of Nasdaq Listing Approval for Majority-Owned Subsidiary Fort Technology

Indeterminate GlobeNewswire

Jun. 4, 2026

Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution

Indeterminate GlobeNewswire

Jun. 4, 2026

Aya Gold & Silver Releases its 2025 Sustainability Report

Indeterminate GlobeNewswire

Jun. 4, 2026

Arvinas Joins The Michael J. Fox Foundation’s LITE and PPMI Programs to Advance New Therapies Targeting LRRK2 for Parkinson’s Disease

Indeterminate GlobeNewswire

Jun. 4, 2026

Onco360® Has Been Selected as a National Specialty Pharmacy Provider for JYLAMVO® (methotrexate) Oral Solution

Indeterminate GlobeNewswire

Jun. 4, 2026

Global-e Announces Board Authorization of $500 Million Share Repurchase Program

Indeterminate GlobeNewswire

Jun. 4, 2026

AEON Biopharma to Present Data Demonstrating Structural and Functional Comparability of ABP-450 to BOTOX® at the 68th Annual Scientific Meeting of the American Headache Society

Indeterminate GlobeNewswire

Jun. 4, 2026

Ocular Therapeutix™ to Participate in Clinical Trials at the Summit 2026

Indeterminate GlobeNewswire

Jun. 4, 2026

Spectral Medical and Vantive Announce Topline 12 Month Follow-Up Results From Spectral’s Tigris Trial

Indeterminate GlobeNewswire

Jun. 4, 2026

The Brain Predicts Social Interaction Before It Starts New Study Finds

Indeterminate GlobeNewswire

Jun. 4, 2026

Pharming announces U.S. FDA acceptance of sNDA resubmission for Joenja® (leniolisib) to treat children aged 4 to 11 years with APDS

Indeterminate GlobeNewswire